Sculptor Capital’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Sculptor Capital’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-125,000	Closed	-$1.24M	–	1259
2021 Q3	$1.24M	Sell	125,000 -125,000	-50%	-$1.25M	0.01%	560
2021 Q2	$2.51M	Buy	+250,000	New	+$2.52M	0.02%	460

Other funds holding ORIAU

JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Sculptor Capital's ORIAU Position: Q4 2021 in Review

Sculptor Capital sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q4 2021, closing a stake of 125,000 shares — an estimated $1.24M sold.

Sculptor Capital first reported a position in ORIAU in Q2 2021 and held it in 2 quarters. The position peaked at $2.51M in Q2 2021. 18 funds tracked by Wall St. Rank hold ORIAU as of Q4 2021.

Sculptor Capital reported no remaining Orion Biotech Opportunities Corp. Units position as of Q4 2021 after selling out during the quarter.
Sculptor Capital sold 125,000 Orion Biotech Opportunities Corp. Units shares in Q4 2021, an estimated $1.24M.
Sculptor Capital first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 2 quarters.
Sculptor Capital's Orion Biotech Opportunities Corp. Units position peaked at $2.51M in Q2 2021.
18 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q4 2021.

Based on Sculptor Capital's 13F filing for Q4 2021, filed 11 Feb 2022.